Neogen Stock Last Dividend Paid
| NEOG Stock | USD 15.31 0.33 2.20% |
Neogen fundamentals help investors to digest information that contributes to Neogen's financial success or failures. It also enables traders to predict the movement of Neogen Stock. The fundamental analysis module provides a way to measure Neogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neogen stock.
Neogen | Last Dividend Paid |
Neogen Company Last Dividend Paid Analysis
Neogen's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Neogen Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Neogen is extremely important. It helps to project a fair market value of Neogen Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Neogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neogen's interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Neogen Additional Paid In Capital
Additional Paid In Capital |
|
Based on the recorded statements, Neogen has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Neogen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Neogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Neogen's managers, analysts, and investors.Environmental | Governance | Social |
Neogen Fundamentals
| Return On Equity | -0.0075 | ||||
| Return On Asset | 0.0085 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 4.02 B | ||||
| Shares Outstanding | 216.7 M | ||||
| Shares Owned By Insiders | 0.26 % | ||||
| Shares Owned By Institutions | 99.74 % | ||||
| Number Of Shares Shorted | 19.68 M | ||||
| Price To Earning | 13.36 X | ||||
| Price To Book | 1.04 X | ||||
| Price To Sales | 3.56 X | ||||
| Revenue | 924.22 M | ||||
| Gross Profit | 409.2 M | ||||
| EBITDA | 182.6 M | ||||
| Net Income | (9.42 M) | ||||
| Cash And Equivalents | 347.71 M | ||||
| Cash Per Share | 3.22 X | ||||
| Total Debt | 906.24 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.07 X | ||||
| Book Value Per Share | 14.47 X | ||||
| Cash Flow From Operations | 35.26 M | ||||
| Short Ratio | 13.20 X | ||||
| Earnings Per Share | (0.11) X | ||||
| Price To Earnings To Growth | 0.66 X | ||||
| Target Price | 16.5 | ||||
| Number Of Employees | 2.92 K | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 3.25 B | ||||
| Total Asset | 4.55 B | ||||
| Retained Earnings | 555.62 M | ||||
| Working Capital | 434.91 M | ||||
| Current Asset | 250 M | ||||
| Current Liabilities | 28.6 M | ||||
| Net Asset | 4.55 B |
About Neogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:Check out Neogen Piotroski F Score and Neogen Altman Z Score analysis. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (0.11) | Revenue Per Share 4.212 | Quarterly Revenue Growth (0.05) | Return On Assets 0.0085 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.